Neoantigens from upstream, downstream and out-of-frame ORFs in breast and ovarian cancer

Use criteria below to search 

arrow&v
arrow&v
Gene
Transcript
Peptide
Modified peptide
Chr
Peptide length
Type
Gene has canonical neoantigen
Wildtype peptide shows affinity
Start
End
Strand
Transcript start
Transcript end
Assigned Modifications
Cancer
PRPF40B
XM_011538136.3
MITSDPMSCSLLR
n[145]M[147]ITSDPM[147]SCSLLR
12
13
3'UTR
yes
yes
49644179
49644448
+
3992
4262
1M(15.9949), 7M(15.9949), 9C(57.0215), N-term(144.1021)
BRCA
PRPF40B
XM_011538137.3
MITSDPMSCSLLR
n[145]M[147]ITSDPMSCSLLR
12
13
3'UTR
yes
yes
49644179
49644448
+
3914
4184
1M(15.9949), 9C(57.0215), N-term(144.1021)
BRCA
PRPF40B
XM_011538137.3
MITSDPMSCSLLR
n[145]M[147]ITSDPMSCSLLR
12
13
3'UTR
yes
yes
49644179
49644448
+
3914
4184
1M(15.9949), 9C(57.0215), N-term(144.1021)
OV
PRPF40B
XM_011538137.3
MITSDPMSCSLLR
n[145]M[147]ITSDPM[147]SCSLLR
12
13
3'UTR
yes
yes
49644179
49644448
+
3914
4184
1M(15.9949), 7M(15.9949), 9C(57.0215), N-term(144.1021)
BRCA
PRPF40B
XM_011538138.3
MITSDPMSCSLLR
n[145]M[147]ITSDPMSCSLLR
12
13
3'UTR
yes
yes
49644179
49644448
+
3884
4154
1M(15.9949), 9C(57.0215), N-term(144.1021)
BRCA
Page 1 of 28